Topic: Major depressive disorder

Reward expectations – one’s prediction about the likelihood of future outcomes - play a central role in shaping the satisfaction derived from those outcomes. Most existing research treats expectations as static, assuming they remain fixed in time. However, real-life expectations are often dynamic, fluctuating as new information becomes available. For example, during a soccer game, your expectations of seeing your team winning will likely rise and fall as the game unfolds. In the main part of this talk, I will present a series of studies demonstrating that human expectations can be tracked at s

Transcranial Magnetic Stimulation (TMS) offers a non-invasive clinical treatment for intractable neuropsychiatric disorders, including Major Depressive Disorder (MDD). Repetitive TMS (rTMS) involves administering a series of patterned magnetic pulses through the skull to modulate cortical brain activity and induce synaptic plasticity in aberrant neural circuitry. When successful, rTMS results in lasting therapeutic changes that may reflect an amelioration in cognitive symptoms. The salient parameters that comprise rTMS protocols, such as pulse frequency, amplitude, etc., interact to determine

Genome-wide association studies (GWAS) have identified multiple disease-associated genetic variations across different psychiatric disorders raising the question of how these genetic variants relate to the corresponding pharmacological treatments. In this talk, I will outline our work investigating whether functional information from a range of open bioinformatics datasets such as protein interaction network (PPI), brain eQTL, and gene expression pattern across the brain can uncover the relationship between GWAS-identified genetic variation and the genes targeted by current drugs for psychiatr

How inclusive and diverse is non-invasive brain stimulation in the treatment of psychiatric disorders?Indira Tendolkar, Donders Institute for Brain, Cognition and Behavior, Department of Psychiatry. Mental illness is associated with a huge socioeconomic burden worldwide, with annual costs only in the Netherlands of €22 billion. Over two decades of cognitive and affective neuroscience research with modern tools of neuroimaging and neurophysiology in humans have given us a wealth of information about neural circuits underlying the main symptom domains of psychiatric disorders and their remediat

Are the immune system, brain, mind and mood related? Could this explain why chronic low-grade peripheral inflammation is also noted in approximately 1/3 of those with major depressive disorder (MDD)? The field recognized today as immunopsychiatry was founded on scientific evidence that germinated over 30 years ago. Since, it has been understood that (i) there could be a causal link between inflammation and depression, (ii) select blood immune markers show robust potential as biomarkers for inflammation-linked depression, and more generally, (iii) Descartes' theories on mind-body dualism were b

Major depressive disorder (MDD) is a sexually dimorphic disease. This sexual dimorphism is believed to result from sex-specific molecular alterations affecting functional pathways regulating the capacity of men and women to cope with daily life stress differently. Transcriptional changes associated with epigenetic alterations have been observed in the brain of men and women with depression and similar changes have been reported in different animal models of stress-induced depressive-like behaviors. In fact, most of our knowledge of the biological basis of MDD is derived from studies of chronic